Suppr超能文献

正常妊娠时胎盘与甲状腺的关系

Placento-thyroidal relationship in normal pregnancy.

作者信息

Kanazawa S, Nakamura A, Saida K, Tojo S

出版信息

Acta Obstet Gynecol Scand. 1976;55(3):201-5. doi: 10.3109/00016347609156913.

Abstract

Estimations of serum HCT, HTSH, T4, T3, PBI, ETR, Triosorb, TBG-binding capacity, BMR and urinary total estrogen were made simultaneously in 160 women in normal pregnancy. TRH stimulation tests were made in 20 cases in each trimester of pregnancy. HCT was detectable even in early pregnancy, tending to increase gradually toward the terminal stage of pregnancy as serum thyrotrophin bioactivity showed. On the other hand, serum TSH level measured by radio-immunoassay remained essentially the same throughout the course of pregnancy as in the nonpregnant state, moreover, it was suggested by the TRH stimulation test that pituitary TSH secreting function of pregnant women was similar to that of the non-pregnant. These findings suggest that thyroid hyperfunction during pregnancy which is shown by progressively increased T3, T4, and PBI may not be due to high estrogen-high TBG binding capacity-low free thyroxinenegative feed back-high TSH secretion but to HCT originating from placenta. In spite of thyroid hormone increase, it is true that the clinical picture of hyperthyroidism is not manifest among normal pregnant women, and ETR remained within the non-pregnant range throughout the course of pregnancy. We have also demonstrated that Triosorb decreased progressively. This may be interpreted to be due to the increase of TBG binding capacity which is increased progressively and binds more of free thyroxine during pregnancy. Such a change in TBG binding capacity is well known to be caused by the effect of estrogen which is progressively increased during pregnancy. In a word, it is possible to say that there is a placento-thyroidal system in pregnancy; HCT elevates thyroid function and TBG increased by estrogen carries thyroid hormone to target organ.

摘要

对160名正常妊娠女性同时进行了血清血细胞比容(HCT)、高灵敏度促甲状腺激素(HTSH)、甲状腺素(T4)、三碘甲状腺原氨酸(T3)、蛋白结合碘(PBI)、雌激素结合率(ETR)、Triosorb、甲状腺素结合球蛋白(TBG)结合能力、基础代谢率(BMR)及尿总雌激素的测定。在妊娠各期对20例孕妇进行了促甲状腺激素释放激素(TRH)刺激试验。即使在妊娠早期也可检测到HCT,随着血清促甲状腺素生物活性的变化,其在妊娠末期有逐渐升高的趋势。另一方面,用放射免疫法测定的血清促甲状腺激素(TSH)水平在整个孕期与非孕期基本相同,此外,TRH刺激试验提示孕妇垂体TSH分泌功能与非孕妇相似。这些发现提示,孕期T3、T4和PBI逐渐升高所显示的甲状腺功能亢进可能并非由于高雌激素-高TBG结合能力-低游离甲状腺素-负反馈-高TSH分泌,而是由于胎盘来源的HCT。尽管甲状腺激素增加,但正常孕妇中确实未表现出甲亢的临床症状,且ETR在整个孕期均保持在非孕期范围内。我们还证实Triosorb逐渐降低。这可能是由于TBG结合能力逐渐增加,在孕期结合了更多的游离甲状腺素。众所周知,这种TBG结合能力的变化是由孕期逐渐增加的雌激素作用引起的。总之,可以说孕期存在胎盘-甲状腺系统;HCT提高甲状腺功能,雌激素增加的TBG将甲状腺激素转运至靶器官。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验